{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29675436", "DateCompleted": {"Year": "2018", "Month": "08", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "02", "Day": "20"}], "Language": ["eng"], "ELocationID": ["6345857", "10.1155/2018/6345857"], "Journal": {"ISSN": "2314-7156", "JournalIssue": {"Volume": "2018", "PubDate": {"Year": "2018"}}, "Title": "Journal of immunology research", "ISOAbbreviation": "J Immunol Res"}, "ArticleTitle": "Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.", "Pagination": {"StartPage": "6345857", "MedlinePgn": "6345857"}, "Abstract": {"AbstractText": ["Numerous studies have examined the pathogenesis of osteoporosis. The causes of osteoporosis include endocrine factors, nutritional status, genetic factors, physical factors, and immune factors. Recent osteoimmunology studies demonstrated that the immune system and immune factors play important regulatory roles in the occurrence of osteoporosis, and people should pay more attention to the relationship between immunity and osteoporosis. Immune and bone cells are located in the bone marrow and share numerous regulatory molecules, signaling molecules, and transcription factors. Abnormal activation of the immune system alters the balance between osteoblasts and osteoclasts, which results in an imbalance of bone remodeling and osteoporosis. The incidence of osteoporosis is also increasing with the aging of China's population, and traditional Chinese medicine has played a vital role in the prevention and treatment of osteoporosis for centuries. Chinese medicinal plants possess unique advantages in the regulation of the immune system and the relationships between osteoporosis and the immune system. In this review, we provide a general overview of Chinese medicinal plants in the prevention and treatment of osteoporosis, focusing on immunological aspects."]}, "AuthorList": [{"Identifier": ["0000-0002-7459-0336"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}, {"Identifier": [], "Affiliation": "Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Science, Beijing 100700, China."}], "LastName": "Zhao", "ForeName": "Hongyan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Clinical Basic Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China."}], "LastName": "Zhao", "ForeName": "Ning", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jilin Provincial Hospital of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130021, China."}], "LastName": "Zheng", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Changchun University of Chinese Medicine, Changchun 130117, China."}], "LastName": "Xu", "ForeName": "Xiaohong", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}, {"Identifier": [], "Affiliation": "Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Science, Beijing 100700, China."}], "LastName": "Liu", "ForeName": "Meijie", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Traditional Chinese Medicine Hospital of Changping District, Beijing 102200, China."}], "LastName": "Luo", "ForeName": "Dan", "Initials": "D"}, {"Identifier": ["0000-0002-4963-3437"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}], "LastName": "Xu", "ForeName": "Huihui", "Initials": "H"}, {"Identifier": ["0000-0001-5903-8175"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}, {"Identifier": [], "Affiliation": "Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Science, Beijing 100700, China."}], "LastName": "Ju", "ForeName": "Dahong", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Egypt", "MedlineTA": "J Immunol Res", "NlmUniqueID": "101627166", "ISSNLinking": "2314-7156"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Bone Remodeling"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immune System"}, {"QualifierName": [], "DescriptorName": "Immunomodulation"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["physiology"], "DescriptorName": "Osteoblasts"}, {"QualifierName": ["physiology"], "DescriptorName": "Osteoclasts"}, {"QualifierName": ["therapy"], "DescriptorName": "Osteoporosis"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "van den Bergh J. P., van Geel T. A., Geusens P. P. Osteoporosis, frailty and fracture: implications for case finding and therapy. Nature Reviews Rheumatology. 2012;8(3):163\u2013172. doi: 10.1038/nrrheum.2011.217.", "ArticleIdList": ["10.1038/nrrheum.2011.217", "22249162"]}, {"Citation": "Limmer A., Wirtz D. C. Osteoimmunology: influence of the immune system on bone regeneration and consumption. Zeitschrift f\u00fcr Orthop\u00e4die und Unfallchirurgie. 2017;155(03):273\u2013280. doi: 10.1055/s-0043-100100.", "ArticleIdList": ["10.1055/s-0043-100100", "28683495"]}, {"Citation": "Weitzmann M. N., Ofotokun I. Physiological and pathophysiological bone turnover\u2014role of the immune system. Nature Reviews Endocrinology. 2016;12(9):518\u2013532. doi: 10.1038/nrendo.2016.91.", "ArticleIdList": ["10.1038/nrendo.2016.91", "PMC5857945", "27312863"]}, {"Citation": "Bozec A., Zaiss M. M. T regulatory cells in bone remodelling. Current Osteoporosis Reports. 2017;15(3):121\u2013125. doi: 10.1007/s11914-017-0356-1.", "ArticleIdList": ["10.1007/s11914-017-0356-1", "28432597"]}, {"Citation": "Zhao L., Huang L., Zhang X. Osteoimmunology: memorandum for rheumatologists. Science China. Life Sciences. 2016;59(12):1241\u20131258. doi: 10.1007/s11427-016-5105-7.", "ArticleIdList": ["10.1007/s11427-016-5105-7", "27650950"]}, {"Citation": "Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nature Reviews Rheumatology. 2009;5(12):667\u2013676. doi: 10.1038/nrrheum.2009.217.", "ArticleIdList": ["10.1038/nrrheum.2009.217", "19884898"]}, {"Citation": "Guerrini M. M., Takayanagi H. The immune system, bone and RANKL. Archives of Biochemistry and Biophysics. 2014;561:118\u2013123. doi: 10.1016/j.abb.2014.06.003.", "ArticleIdList": ["10.1016/j.abb.2014.06.003", "24929185"]}, {"Citation": "Nakashima T., Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. Journal of Clinical Immunology. 2009;29(5):555\u2013567. doi: 10.1007/s10875-009-9316-6.", "ArticleIdList": ["10.1007/s10875-009-9316-6", "19585227"]}, {"Citation": "Wang Z. Q., Li J. L., Sun Y. L., et al. Chinese herbal medicine for osteoporosis: a systematic review of randomized controlled trails. Evidence-based Complementary and Alternative Medicine. 2013;2013:11. doi: 10.1155/2013/356260.356260", "ArticleIdList": ["10.1155/2013/356260", "PMC3572690", "23431336"]}, {"Citation": "He J. B., Chen M. H., Lin D. K. New insights into the tonifying k`in herbs and formulas for the treatment of osteoporosis. Archives of Osteoporosis. 2017;12(1):p. 14. doi: 10.1007/s11657-016-0301-4.", "ArticleIdList": ["10.1007/s11657-016-0301-4", "28127706"]}, {"Citation": "Tong L., Moudgil K. D. Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Research & Therapy. 2007;9(4, article R70) doi: 10.1186/ar2268.", "ArticleIdList": ["10.1186/ar2268", "PMC2206370", "17645785"]}, {"Citation": "Ma A., Yang Y., Wang Q., Wang Y., Wen J., Zhang Y. Antiinflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells. Molecular Medicine Reports. 2017;15(6):3615\u20133622. doi: 10.3892/mmr.2017.6484.", "ArticleIdList": ["10.3892/mmr.2017.6484", "PMC5436225", "28440447"]}, {"Citation": "Chen T., Yuan S., Wan X. N., et al. Chinese herb cinobufagin-reduced cancer pain is associated with increased peripheral opioids by invaded CD3/4/8 lymphocytes. Oncotarget. 2017;8(7):11425\u201311441. doi: 10.18632/oncotarget.14005.", "ArticleIdList": ["10.18632/oncotarget.14005", "PMC5355276", "28002791"]}, {"Citation": "Park S. Y., Jung S. J., Ha K. C., et al. Anti-inflammatory effects of Cordyceps mycelium (Paecilomyces hepiali, CBG-CS-2) in Raw264.7 murine macrophages. Oriental Pharmacy and Experimental Medicine. 2015;15(1):7\u201312. doi: 10.1007/s13596-014-0173-3.", "ArticleIdList": ["10.1007/s13596-014-0173-3", "PMC4371127", "25814919"]}, {"Citation": "Xiao C., Zhao L., Liu Z., et al. The effect of triptolide on CD4+ and CD8+ cells in the Peyer\u2019s patch of DA rats with collagen induced arthritis. Natural Product Research. 2009;23(18):1699\u20131706. doi: 10.1080/14786410802187783.", "ArticleIdList": ["10.1080/14786410802187783", "19921588"]}, {"Citation": "Ho L. J., Lai J. H. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Current Drug Metabolism. 2004;5(2):181\u2013192. doi: 10.2174/1389200043489081.", "ArticleIdList": ["10.2174/1389200043489081", "15078195"]}, {"Citation": "Asano K., Matsuishi J., Yu Y., Kasahara T., Hisamitsu T. Suppressive effects of Tripterygium wilfordii Hook f., a traditional Chinese medicine, on collagen arthritis in mice. Immunopharmacology. 1998;39(2):117\u2013126. doi: 10.1016/S0162-3109(98)00006-X.", "ArticleIdList": ["10.1016/S0162-3109(98)00006-X", "9716258"]}, {"Citation": "Tawfik A. F., Bishop S. J., Ayalp A., el-Feraly F. S. Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice. International Journal of Immunopharmacology. 1990;12(4):385\u2013389. doi: 10.1016/0192-0561(90)90019-J.", "ArticleIdList": ["10.1016/0192-0561(90)90019-J", "2202689"]}, {"Citation": "Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nature Reviews Immunology. 2007;7(4):292\u2013304. doi: 10.1038/nri2062.", "ArticleIdList": ["10.1038/nri2062", "17380158"]}, {"Citation": "Greenblatt M. B., Shim J. H. Osteoimmunology: a brief introduction. Immune Network. 2013;13(4):111\u2013115. doi: 10.4110/in.2013.13.4.111.", "ArticleIdList": ["10.4110/in.2013.13.4.111", "PMC3759707", "24009537"]}, {"Citation": "Takayanagi H. Osteoimmunology in 2014: two-faced immunology-from osteogenesis to bone resorption. Nature Reviews Rheumatology. 2015;11(2):74\u201376. doi: 10.1038/nrrheum.2014.219.", "ArticleIdList": ["10.1038/nrrheum.2014.219", "25561367"]}, {"Citation": "Boyle W. J., Simonet W. S., Lacey D. L. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u2013342. doi: 10.1038/nature01658.", "ArticleIdList": ["10.1038/nature01658", "12748652"]}, {"Citation": "Walsh M. C., Choi Y. Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Frontiers in Immunology. 2014;5:p. 511. doi: 10.3389/fimmu.2014.00511.", "ArticleIdList": ["10.3389/fimmu.2014.00511", "PMC4202272", "25368616"]}, {"Citation": "Ginaldi L., De Martinis M. Osteoimmunology and beyond. Current Medicinal Chemistry. 2016;23(33):3754\u20133774. doi: 10.2174/0929867323666160907162546.", "ArticleIdList": ["10.2174/0929867323666160907162546", "PMC5204071", "27604089"]}, {"Citation": "Mori G., D'Amelio P., Faccio R., Brunetti G. The interplay between the bone and the immune system. Clinical and Developmental Immunology. 2013;2013:16. doi: 10.1155/2013/720504.720504", "ArticleIdList": ["10.1155/2013/720504", "PMC3725924", "23935650"]}, {"Citation": "Ikeda T., Utsuyama M., Hirokawa K. Expression profiles of receptor activator of nuclear factor \u03baB ligand, receptor activator of nuclear factor \u03baB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. Journal of Bone and Mineral Research. 2001;16(8):1416\u20131425. doi: 10.1359/jbmr.2001.16.8.1416.", "ArticleIdList": ["10.1359/jbmr.2001.16.8.1416", "11499864"]}, {"Citation": "Kim J. H., Kim N. Regulation of NFATc1 in osteoclast differentiation. Journal of Bone Metabolism. 2014;21(4):233\u2013241. doi: 10.11005/jbm.2014.21.4.233.", "ArticleIdList": ["10.11005/jbm.2014.21.4.233", "PMC4255043", "25489571"]}, {"Citation": "Lacey D. L., Timms E., Tan H. L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93(2):165\u2013176. doi: 10.1016/S0092-8674(00)81569-X.", "ArticleIdList": ["10.1016/S0092-8674(00)81569-X", "9568710"]}, {"Citation": "Simonet W. S., Lacey D. L., Dunstan C. R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309\u2013319. doi: 10.1016/S0092-8674(00)80209-3.", "ArticleIdList": ["10.1016/S0092-8674(00)80209-3", "9108485"]}, {"Citation": "Wolski H., Drews K., Bogacz A., et al. The RANKL/RANK/OPG signal trail: significance of genetic polymorphisms in the etiology of postmenopausal osteoporosis. Ginekologia Polska. 2016;87(5):347\u2013352. doi: 10.5603/GP.2016.0014.", "ArticleIdList": ["10.5603/GP.2016.0014", "27304650"]}, {"Citation": "Hamdy N. A. Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis. Current Opinion in Investigational Drugs. 2007;8(4):299\u2013303.", "ArticleIdList": ["17458179"]}, {"Citation": "Hofbauer L. C., Kuhne C. A., Viereck V. The OPG/RANKL/RANK system in metabolic bone diseases. Journal of Musculoskeletal & Neuronal Interactions. 2004;4(3):268\u2013275.", "ArticleIdList": ["15615494"]}, {"Citation": "Weitzmann M. N. The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica. 2013;2013:29. doi: 10.1155/2013/125705.125705", "ArticleIdList": ["10.1155/2013/125705", "PMC3820310", "24278766"]}, {"Citation": "Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142(12):5050\u20135055. doi: 10.1210/endo.142.12.8536.", "ArticleIdList": ["10.1210/endo.142.12.8536", "11713196"]}, {"Citation": "Xu F., Dong Y., Huang X., et al. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis. Molecular Medicine Reports. 2016;14(3):2289\u20132296. doi: 10.3892/mmr.2016.5515.", "ArticleIdList": ["10.3892/mmr.2016.5515", "27430581"]}, {"Citation": "Okamoto K., Takayanagi H. Regulation of bone by the adaptive immune system in arthritis. Arthritis Research & Therapy. 2011;13(3):p. 219. doi: 10.1186/ar3323.", "ArticleIdList": ["10.1186/ar3323", "PMC3218874", "21635718"]}, {"Citation": "Li J. Y., Tawfeek H., Bedi B., et al. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(2):768\u2013773. doi: 10.1073/pnas.1013492108.", "ArticleIdList": ["10.1073/pnas.1013492108", "PMC3021053", "21187391"]}, {"Citation": "Sato K., Suematsu A., Okamoto K., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. The Journal of Experimental Medicine. 2006;203(12):2673\u20132682. doi: 10.1084/jem.20061775.", "ArticleIdList": ["10.1084/jem.20061775", "PMC2118166", "17088434"]}, {"Citation": "Zaiss M. M., Axmann R., Zwerina J., et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis & Rheumatism. 2007;56(12):4104\u20134112. doi: 10.1002/art.23138.", "ArticleIdList": ["10.1002/art.23138", "18050211"]}, {"Citation": "Zaiss M. M., Frey B., Hess A., et al. Regulatory T cells protect from local and systemic bone destruction in arthritis. The Journal of Immunology. 2010;184(12):7238\u20137246. doi: 10.4049/jimmunol.0903841.", "ArticleIdList": ["10.4049/jimmunol.0903841", "20483756"]}, {"Citation": "Lee S. Y., Jung Y. O., Ryu J. G., et al. Intravenous immunoglobulin attenuates experimental autoimmune arthritis by inducing reciprocal regulation of Th17 and Treg cells in an interleukin-10-dependent manner. Arthritis & Rheumatology. 2014;66(7):1768\u20131778. doi: 10.1002/art.38627.", "ArticleIdList": ["10.1002/art.38627", "24644005"]}, {"Citation": "Xu H., Zhao H., Lu C., et al. Triptolide inhibits osteoclast differentiation and bone resorption in vitro via enhancing the production of IL-10 and TGF-\u03b21 by regulatory T cells. Mediators of Inflammation. 2016;2016:10. doi: 10.1155/2016/8048170.8048170", "ArticleIdList": ["10.1155/2016/8048170", "PMC4930824", "27413257"]}, {"Citation": "Wing K., Onishi Y., Prieto-Martin P., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008;322(5899):271\u2013275. doi: 10.1126/science.1160062.", "ArticleIdList": ["10.1126/science.1160062", "18845758"]}, {"Citation": "Axmann R., Herman S., Zaiss M., et al. CTLA-4 directly inhibits osteoclast formation. Annals of the Rheumatic Diseases. 2008;67(11):1603\u20131609. doi: 10.1136/ard.2007.080713.", "ArticleIdList": ["10.1136/ard.2007.080713", "18203760"]}, {"Citation": "Pene J., Chevalier S., Preisser L., et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. The Journal of Immunology. 2008;180(11):7423\u20137430. doi: 10.4049/jimmunol.180.11.7423.", "ArticleIdList": ["10.4049/jimmunol.180.11.7423", "18490742"]}, {"Citation": "Takayanagi H. New immune connections in osteoclast formation. Annals of the New York Academy of Sciences. 2010;1192(1):117\u2013123. doi: 10.1111/j.1749-6632.2009.05303.x.", "ArticleIdList": ["10.1111/j.1749-6632.2009.05303.x", "20392226"]}, {"Citation": "Tyagi A. M., Srivastava K., Mansoori M. N., Trivedi R., Chattopadhyay N., Singh D. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One. 2012;7(9, article e44552) doi: 10.1371/journal.pone.0044552.", "ArticleIdList": ["10.1371/journal.pone.0044552", "PMC3438183", "22970248"]}, {"Citation": "Romas E., Gillespie M. T., Martin T. J. Involvement of receptor activator of NF\u03baB ligand and tumor necrosis factor-\u03b1 in bone destruction in rheumatoid arthritis. Bone. 2002;30(2):340\u2013346. doi: 10.1016/S8756-3282(01)00682-2.", "ArticleIdList": ["10.1016/S8756-3282(01)00682-2", "11856640"]}, {"Citation": "Takegahara N., Kim H., Mizuno H., et al. Involvement of receptor activator of nuclear factor-\u03baB ligand (RANKL)-induced incomplete cytokinesis in the polyploidization of osteoclasts. The Journal of Biological Chemistry. 2016;291(7):3439\u20133454. doi: 10.1074/jbc.M115.677427.", "ArticleIdList": ["10.1074/jbc.M115.677427", "PMC4751386", "26670608"]}, {"Citation": "Li Y., Toraldo G., Li A., et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007;109(9):3839\u20133848. doi: 10.1182/blood-2006-07-037994.", "ArticleIdList": ["10.1182/blood-2006-07-037994", "PMC1874582", "17202317"]}, {"Citation": "Yun T. J., Chaudhary P. M., Shu G. L., et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. Journal of Immunology. 1998;161(11):6113\u20136121.", "ArticleIdList": ["9834095"]}, {"Citation": "Titanji K., Vunnava A., Sheth A. N., et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. PLoS Pathogens. 2014;10(11, article e1004497) doi: 10.1371/journal.ppat.1004497.", "ArticleIdList": ["10.1371/journal.ppat.1004497", "PMC4231117", "25393853"]}, {"Citation": "Kong Y. Y., Yoshida H., Sarosi I., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397(6717):315\u2013323. doi: 10.1038/16852.", "ArticleIdList": ["10.1038/16852", "9950424"]}, {"Citation": "Ehrhardt G. R., Hijikata A., Kitamura H., Ohara O., Wang J. Y., Cooper M. D. Discriminating gene expression profiles of memory B cell subpopulations. The Journal of Experimental Medicine. 2008;205(8):1807\u20131817. doi: 10.1084/jem.20072682.", "ArticleIdList": ["10.1084/jem.20072682", "PMC2525601", "18625746"]}, {"Citation": "Amara K., Clay E., Yeo L., et al. B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis. Journal of Autoimmunity. 2017;81:34\u201343. doi: 10.1016/j.jaut.2017.03.004.", "ArticleIdList": ["10.1016/j.jaut.2017.03.004", "PMC5473332", "28343748"]}, {"Citation": "Pesce Viglietti A. I., Arriola Benitez P. C., Giambartolomei G. H., Delpino M. V. Brucella abortus-infected B cells induce osteoclastogenesis. Microbes and Infection. 2016;18(9):529\u2013535. doi: 10.1016/j.micinf.2016.04.001.", "ArticleIdList": ["10.1016/j.micinf.2016.04.001", "27109230"]}, {"Citation": "Jarry C. R., Martinez E. F., Peruzzo D. C., et al. Expression of SOFAT by T- and B-lineage cells may contribute to bone loss. Molecular Medicine Reports. 2016;13(5):4252\u20134258. doi: 10.3892/mmr.2016.5045.", "ArticleIdList": ["10.3892/mmr.2016.5045", "PMC4838117", "27035849"]}, {"Citation": "Xu S., Zhang Y., Liu B., et al. Activation of mTORC1 in B lymphocytes promotes osteoclast formation via regulation of \u03b2-catenin and RANKL/OPG. Journal of Bone and Mineral Research. 2016;31(7):1320\u20131333. doi: 10.1002/jbmr.2800.", "ArticleIdList": ["10.1002/jbmr.2800", "26825871"]}, {"Citation": "Azizieh F., Raghupathy R., Shehab D., Al-Jarallah K., Gupta R. Cytokine profiles in osteoporosis suggest a proresorptive bias. Menopause. 2017;24(9):1057\u20131064. doi: 10.1097/GME.0000000000000885.", "ArticleIdList": ["10.1097/GME.0000000000000885", "28609384"]}, {"Citation": "Eghbali-Fatourechi G., Khosla S., Sanyal A., Boyle W. J., Lacey D. L., Riggs B. L. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. The Journal of Clinical Investigation. 2003;111(8):1221\u20131230. doi: 10.1172/JCI200317215.", "ArticleIdList": ["10.1172/JCI200317215", "PMC152939", "12697741"]}, {"Citation": "Hofbauer L. C., Khosla S., Dunstan C. R., Lacey D. L., Boyle W. J., Riggs B. L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Journal of Bone and Mineral Research. 2000;15(1):2\u201312. doi: 10.1359/jbmr.2000.15.1.2.", "ArticleIdList": ["10.1359/jbmr.2000.15.1.2", "10646108"]}, {"Citation": "Wei S., Wang M. W., Teitelbaum S. L., Ross F. P. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-\u03baB and mitogen-activated protein kinase signaling. The Journal of Biological Chemistry. 2002;277(8):6622\u20136630. doi: 10.1074/jbc.M104957200.", "ArticleIdList": ["10.1074/jbc.M104957200", "11719504"]}, {"Citation": "Owens J. M., Gallagher A. C., Chambers T. J. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. Journal of Immunology. 1996;157(2):936\u2013940.", "ArticleIdList": ["8752948"]}, {"Citation": "Morita Y., Kitaura H., Yoshimatsu M., et al. IL-18 inhibits TNF-\u03b1-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo. Calcified Tissue International. 2010;86(3):242\u2013248. doi: 10.1007/s00223-010-9335-6.", "ArticleIdList": ["10.1007/s00223-010-9335-6", "20111957"]}, {"Citation": "Horwood N. J., Elliott J., Martin T. J., Gillespie M. T. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. The Journal of Immunology. 2001;166(8):4915\u20134921. doi: 10.4049/jimmunol.166.8.4915.", "ArticleIdList": ["10.4049/jimmunol.166.8.4915", "11290769"]}, {"Citation": "Kim S. Y., Schneeweiss S., Liu J., et al. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Research & Therapy. 2010;12(4):p. R154. doi: 10.1186/ar3107.", "ArticleIdList": ["10.1186/ar3107", "PMC2945054", "20682035"]}, {"Citation": "Mermerci Ba\u015fkan B., Pekin Do\u011fan Y., Sivas F., Bodur H., Ozoran K. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatology International. 2010;30(3):375\u2013381. doi: 10.1007/s00296-009-0975-7.", "ArticleIdList": ["10.1007/s00296-009-0975-7", "19685057"]}, {"Citation": "Davey-Ranasinghe N., Deodhar A. Osteoporosis and vertebral fractures in ankylosing spondylitis. Current Opinion in Rheumatology. 2013;25(4):509\u2013516. doi: 10.1097/BOR.0b013e3283620777.", "ArticleIdList": ["10.1097/BOR.0b013e3283620777", "23719363"]}, {"Citation": "Jung S. M., Kim K. W., Yang C. W., Park S. H., Ju J. H. Cytokine-mediated bone destruction in rheumatoid arthritis. Journal of Immunology Research. 2014;2014:15. doi: 10.1155/2014/263625.263625", "ArticleIdList": ["10.1155/2014/263625", "PMC4176903", "25295284"]}, {"Citation": "Rufus P., Mohamed N., Shuid A. N. Beneficial effects of traditional Chinese medicine on the treatment of osteoporosis on ovariectomised rat models. Current Drug Targets. 2013;14(14):1689\u20131693. doi: 10.2174/1389450114666131220160357.", "ArticleIdList": ["10.2174/1389450114666131220160357", "24354584"]}, {"Citation": "Yamasaki H. Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Medica Okayama. 1976;30(1):1\u201320.", "ArticleIdList": ["61710"]}, {"Citation": "Wang Q., Li X. K. Immunosuppressive and anti-inflammatory activities of sinomenine. International Immunopharmacology. 2011;11(3):373\u2013376. doi: 10.1016/j.intimp.2010.11.018.", "ArticleIdList": ["10.1016/j.intimp.2010.11.018", "21109035"]}, {"Citation": "Liu L., Resch K., Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. International Journal of Immunopharmacology. 1994;16(8):685\u2013691. doi: 10.1016/0192-0561(94)90142-2.", "ArticleIdList": ["10.1016/0192-0561(94)90142-2", "7989137"]}, {"Citation": "Cheng Y., Zhang J., Hou W., et al. Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis. International Immunopharmacology. 2009;9(7-8):894\u2013899. doi: 10.1016/j.intimp.2009.03.014.", "ArticleIdList": ["10.1016/j.intimp.2009.03.014", "19336263"]}, {"Citation": "Yan L. C., Bi E. G., Lou Y. T., et al. Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis. Biochemical and Biophysical Research Communications. 2010;391(1):1093\u20131098. doi: 10.1016/j.bbrc.2009.12.028.", "ArticleIdList": ["10.1016/j.bbrc.2009.12.028", "20004644"]}, {"Citation": "Liu L., Buchner E., Beitze D., et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. International Journal of Immunopharmacology. 1996;18(10):529\u2013543. doi: 10.1016/S0192-0561(96)00025-2.", "ArticleIdList": ["10.1016/S0192-0561(96)00025-2", "9080247"]}, {"Citation": "Feng H., Yamaki K., Takano H., Inoue K., Yanagisawa R., Yoshino S. Effect of sinomenine on collagen-induced arthritis in mice. Autoimmunity. 2009;40(7):532\u2013539. doi: 10.1080/08916930701615159.", "ArticleIdList": ["10.1080/08916930701615159", "17966044"]}, {"Citation": "Zhou H., Wong Y. F., Wang J., Cai X., Liu L. Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats. Biochemical and Biophysical Research Communications. 2008;376(2):352\u2013357. doi: 10.1016/j.bbrc.2008.08.153.", "ArticleIdList": ["10.1016/j.bbrc.2008.08.153", "18782565"]}, {"Citation": "Li X., He L., Hu Y., et al. Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways. PLoS One. 2013;8(9, article e74274) doi: 10.1371/journal.pone.0074274.", "ArticleIdList": ["10.1371/journal.pone.0074274", "PMC3774760", "24066131"]}, {"Citation": "Zhou B., Lu X., Tang Z., et al. Influence of sinomenine upon mesenchymal stem cells in osteoclastogenesis. Biomedicine & Pharmacotherapy. 2017;90:835\u2013841. doi: 10.1016/j.biopha.2017.03.084.", "ArticleIdList": ["10.1016/j.biopha.2017.03.084", "28437887"]}, {"Citation": "He L., Duan H., Li X., et al. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis. European Journal of Pharmacology. 2016;779:66\u201379. doi: 10.1016/j.ejphar.2016.03.014.", "ArticleIdList": ["10.1016/j.ejphar.2016.03.014", "26965104"]}, {"Citation": "Kawaguchi K., Maruyama H., Hasunuma R., Kumazawa Y. Suppression of inflammatory responses after onset of collagen-induced arthritis in mice by oral administration of the Citrus flavanone naringin. Immunopharmacology and Immunotoxicology. 2011;33(4):723\u2013729. doi: 10.3109/08923973.2011.564186.", "ArticleIdList": ["10.3109/08923973.2011.564186", "21480758"]}, {"Citation": "Ang E. S., Yang X., Chen H., Liu Q., Zheng M. H., Xu J. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-\u03baB and ERK activation. FEBS Letters. 2011;585(17):2755\u20132762. doi: 10.1016/j.febslet.2011.07.046.", "ArticleIdList": ["10.1016/j.febslet.2011.07.046", "21835177"]}, {"Citation": "Wu J. B., Fong Y. C., Tsai H. Y., Chen Y. F., Tsuzuki M., Tang C. H. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. European Journal of Pharmacology. 2008;588(2-3):333\u2013341. doi: 10.1016/j.ejphar.2008.04.030.", "ArticleIdList": ["10.1016/j.ejphar.2008.04.030", "18495116"]}, {"Citation": "Wong K. C., Pang W. Y., Wang X. L., et al. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. The British Journal of Nutrition. 2013;110(3):475\u2013485. doi: 10.1017/S0007114512005405.", "ArticleIdList": ["10.1017/S0007114512005405", "23302510"]}, {"Citation": "Pang W. Y., Wang X. L., Mok S. K., et al. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. British Journal of Pharmacology. 2010;159(8):1693\u20131703. doi: 10.1111/j.1476-5381.2010.00664.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00664.x", "PMC2925492", "20397301"]}, {"Citation": "Lin F. X., Du S. X., Liu D. Z., et al. Naringin promotes osteogenic differentiation of bone marrow stromal cells by up-regulating Foxc2 expression via the IHH signaling pathway. American Journal of Translational Research. 2016;8(11):5098\u20135107.", "ArticleIdList": ["PMC5126353", "27904711"]}, {"Citation": "Xu J. H., Yao M., Ye J., et al. Bone mass improved effect of icariin for postmenopausal osteoporosis in ovariectomy-induced rats: a meta-analysis and systematic review. Menopause. 2016;23(10):1152\u20131157. doi: 10.1097/GME.0000000000000673.", "ArticleIdList": ["10.1097/GME.0000000000000673", "27648597"]}, {"Citation": "Xue L., Jiang Y., Han T., et al. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim. Journal of Ethnopharmacology. 2016;192:370\u2013381. doi: 10.1016/j.jep.2016.07.037.", "ArticleIdList": ["10.1016/j.jep.2016.07.037", "27422162"]}, {"Citation": "Chen G., Wang C., Wang J., et al. Antiosteoporotic effect of icariin in ovariectomized rats is mediated via the Wnt/\u03b2-catenin pathway. Experimental and Therapeutic Medicine. 2016;12(1):279\u2013287. doi: 10.3892/etm.2016.3333.", "ArticleIdList": ["10.3892/etm.2016.3333", "PMC4906828", "27347050"]}, {"Citation": "Qin S., Zhou W., Liu S., Chen P., Wu H. Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling. International Journal of Clinical and Experimental Medicine. 2015;8(5):7125\u20137133.", "ArticleIdList": ["PMC4509195", "26221250"]}, {"Citation": "Li G. W., Xu Z., Chang S. X., Nian H., Wang X. Y., Qin L. D. Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis. Menopause. 2014;21(9):1007\u20131016. doi: 10.1097/GME.0000000000000201.", "ArticleIdList": ["10.1097/GME.0000000000000201", "24552978"]}, {"Citation": "Liu H., Xiong Y., Zhu X., et al. Icariin improves osteoporosis, inhibits the expression of PPAR\u03b3, C/EBP\u03b1, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats. Experimental and Therapeutic Medicine. 2017;13(4):1360\u20131368. doi: 10.3892/etm.2017.4128.", "ArticleIdList": ["10.3892/etm.2017.4128", "PMC5377361", "28413478"]}, {"Citation": "Cao H., Zhang Y., Qian W., et al. Effect of icariin on fracture healing in an ovariectomized rat model of osteoporosis. Experimental and Therapeutic Medicine. 2017;13(5):2399\u20132404. doi: 10.3892/etm.2017.4233.", "ArticleIdList": ["10.3892/etm.2017.4233", "PMC5443263", "28565854"]}, {"Citation": "Wu Y., Cao L., Xia L., et al. Evaluation of osteogenesis and angiogenesis of icariin in local controlled release and systemic delivery for calvarial defect in ovariectomized rats. Scientific Reports. 2017;7(1, article 5077) doi: 10.1038/s41598-017-05392-z.", "ArticleIdList": ["10.1038/s41598-017-05392-z", "PMC5505963", "28698566"]}, {"Citation": "Hsieh T. P., Sheu S. Y., Sun J. S., Chen M. H., Liu M. H. Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine. 2010;17(6):414\u2013423. doi: 10.1016/j.phymed.2009.08.007.", "ArticleIdList": ["10.1016/j.phymed.2009.08.007", "19747809"]}, {"Citation": "Liang W., Lin M., Li X., et al. Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. International Journal of Molecular Medicine. 2012;30(4):889\u2013895. doi: 10.3892/ijmm.2012.1079.", "ArticleIdList": ["10.3892/ijmm.2012.1079", "22842877"]}, {"Citation": "Tan E. M., Li L., Indran I. R., Chew N., Yong E. L. TRAF6 mediates suppression of osteoclastogenesis and prevention of ovariectomy-induced bone loss by a novel prenylflavonoid. Journal of Bone and Mineral Research. 2017;32(4):846\u2013860. doi: 10.1002/jbmr.3031.", "ArticleIdList": ["10.1002/jbmr.3031", "27813153"]}, {"Citation": "Wu T., Shu T., Kang L., et al. Icaritin, a novel plant-derived osteoinductive agent, enhances the osteogenic differentiation of human bone marrow- and human adipose tissue-derived mesenchymal stem cells. International Journal of Molecular Medicine. 2017;39(4):984\u2013992. doi: 10.3892/ijmm.2017.2906.", "ArticleIdList": ["10.3892/ijmm.2017.2906", "28260001"]}, {"Citation": "Sheng H., Rui X. F., Sheng C. J., et al. A novel semisynthetic molecule icaritin stimulates osteogenic differentiation and inhibits adipogenesis of mesenchymal stem cells. International Journal of Medical Sciences. 2013;10(6):782\u2013789. doi: 10.7150/ijms.6084.", "ArticleIdList": ["10.7150/ijms.6084", "PMC3638303", "23630444"]}, {"Citation": "Ha H., Ho J., Shin S., et al. Effects of Eucommiae Cortex on osteoblast-like cell proliferation and osteoclast inhibition. Archives of Pharmacal Research. 2003;26(11):929\u2013936. doi: 10.1007/BF02980202.", "ArticleIdList": ["10.1007/BF02980202", "14661859"]}, {"Citation": "Zhang R., Liu Z. G., Li C., et al. Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats. Bone. 2009;45(3):553\u2013559. doi: 10.1016/j.bone.2008.08.127.", "ArticleIdList": ["10.1016/j.bone.2008.08.127", "18835589"]}, {"Citation": "Li Y., Wang M. J., Li S., et al. Effect of total glycosides from Eucommia ulmoides seed on bone microarchitecture in rats. Phytotherapy Research. 2011;25(12):1895\u20131897. doi: 10.1002/ptr.3543.", "ArticleIdList": ["10.1002/ptr.3543", "21674630"]}, {"Citation": "Zhang W., Fujikawa T., Mizuno K., et al. Eucommia leaf extract (ELE) prevents OVX-induced osteoporosis and obesity in rats. The American Journal of Chinese Medicine. 2012;40(04):735\u2013752. doi: 10.1142/S0192415X12500553.", "ArticleIdList": ["10.1142/S0192415X12500553", "22809028"]}, {"Citation": "Tan X. L., Zhang Y. H., Cai J. P., Zhu L. H., Ge W. J., Zhang X. 5-(Hydroxymethyl)-2-furaldehyde inhibits adipogenic and enhances osteogenic differentiation of rat bone mesenchymal stem cells. Natural Product Communications. 2014;9(4):529\u2013532.", "ArticleIdList": ["24868876"]}, {"Citation": "Zhang R., Pan Y. L., Hu S. J., Kong X. H., Juan W., Mei Q. B. Effects of total lignans from Eucommia ulmoides barks prevent bone loss in vivo and in vitro. Journal of Ethnopharmacology. 2014;155(1):104\u2013112. doi: 10.1016/j.jep.2014.04.031.", "ArticleIdList": ["10.1016/j.jep.2014.04.031", "24786573"]}, {"Citation": "Wang J. Y., Yuan Y., Chen X. J., et al. Extract from Eucommia ulmoides Oliv. ameliorates arthritis via regulation of inflammation, synoviocyte proliferation and osteoclastogenesis in vitro and in vivo. Journal of Ethnopharmacology. 2016;194:609\u2013616. doi: 10.1016/j.jep.2016.10.038.", "ArticleIdList": ["10.1016/j.jep.2016.10.038", "27743778"]}, {"Citation": "Xie G. P., Jiang N., Wang S. N., et al. Eucommia ulmoides Oliv. bark aqueous extract inhibits osteoarthritis in a rat model of osteoarthritis. Journal of Ethnopharmacology. 2015;162:148\u2013154. doi: 10.1016/j.jep.2014.12.061.", "ArticleIdList": ["10.1016/j.jep.2014.12.061", "25575468"]}, {"Citation": "Kwon S. H., Ma S. X., Hwang J. Y., et al. The anti-inflammatory activity of Eucommia ulmoides Oliv. bark. involves NF-\u03baB suppression and Nrf2-dependent HO-1 induction in BV-2 microglial cells. Biomolecules & Therapeutics. 2016;24(3):268\u2013282. doi: 10.4062/biomolther.2015.150.", "ArticleIdList": ["10.4062/biomolther.2015.150", "PMC4859790", "27068259"]}, {"Citation": "Dai X., Huang Q., Zhou B., Gong Z., Liu Z., Shi S. Preparative isolation and purification of seven main antioxidants from Eucommia ulmoides Oliv. (Du-zhong) leaves using HSCCC guided by DPPH-HPLC experiment. Food Chemistry. 2013;139(1\u20134):563\u2013570. doi: 10.1016/j.foodchem.2013.02.006.", "ArticleIdList": ["10.1016/j.foodchem.2013.02.006", "23561146"]}, {"Citation": "Bai M. M., Shi W., Tian J. M., et al. Soluble epoxide hydrolase inhibitory and anti-inflammatory components from the leaves of Eucommia ulmoides Oliver (Duzhong) Journal of Agricultural and Food Chemistry. 2015;63(8):2198\u20132205. doi: 10.1021/acs.jafc.5b00055.", "ArticleIdList": ["10.1021/acs.jafc.5b00055", "25679330"]}, {"Citation": "Oliveira T., Figueiredo C. A., Brito C., et al. Allium cepa L. and quercetin inhibit RANKL/porphyromonas gingivalis LPS-induced osteoclastogenesis by downregulating NF-\u03baB signaling pathway. Evidence-Based Complementary and Alternative Medicine. 2015;2015:11. doi: 10.1155/2015/704781.704781", "ArticleIdList": ["10.1155/2015/704781", "PMC4529940", "26273314"]}, {"Citation": "Shim K. S., Ha H., Kim T., Lee C. J., Ma J. Y. Orostachys japonicus suppresses osteoclast differentiation by inhibiting NFATc1 expression. The American Journal of Chinese Medicine. 2015;43(05):1013\u20131030. doi: 10.1142/S0192415X15500585.", "ArticleIdList": ["10.1142/S0192415X15500585", "26205967"]}, {"Citation": "Wattel A., Kamel S., Prouillet C., et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF \u03baB and AP-1. Journal of Cellular Biochemistry. 2004;92(2):285\u2013295. doi: 10.1002/jcb.20071.", "ArticleIdList": ["10.1002/jcb.20071", "15108355"]}, {"Citation": "Tsuji M., Yamamoto H., Sato T., et al. Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice. Journal of Bone and Mineral Metabolism. 2009;27(6):673\u2013681. doi: 10.1007/s00774-009-0088-0.", "ArticleIdList": ["10.1007/s00774-009-0088-0", "19495926"]}, {"Citation": "Woo J. T., Nakagawa H., Notoya M., et al. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biological and Pharmaceutical Bulletin. 2004;27(4):504\u2013509. doi: 10.1248/bpb.27.504.", "ArticleIdList": ["10.1248/bpb.27.504", "15056855"]}, {"Citation": "Yamaguchi M., Weitzmann M. Quercetin, a potent suppressor of NF-\u03baB and Smad activation in osteoblasts. International Journal of Molecular Medicine. 2011;28(4):521\u2013525. doi: 10.3892/ijmm.2011.749.", "ArticleIdList": ["10.3892/ijmm.2011.749", "21769418"]}, {"Citation": "Guo C., Hou G. Q., Li X. D., et al. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cellular Physiology and Biochemistry. 2012;30(1):123\u2013136. doi: 10.1159/000339052.", "ArticleIdList": ["10.1159/000339052", "22759961"]}, {"Citation": "Yamaguchi M., Hamamoto R., Uchiyama S., Ishiyama K. Effects of flavonoid on calcium content in femoral tissue culture and parathyroid hormone-stimulated osteoclastogenesis in bone marrow culture in vitro. Molecular and Cellular Biochemistry. 2007;303(1-2):83\u201388. doi: 10.1007/s11010-007-9458-x.", "ArticleIdList": ["10.1007/s11010-007-9458-x", "17541507"]}, {"Citation": "Wang X. C., Zhao N. J., Guo C., Chen J. T., Song J. L., Gao L. Quercetin reversed lipopolysaccharide-induced inhibition of osteoblast differentiation through the mitogen-activated protein kinase pathway in MC3T3-E1 cells. Molecular Medicine Reports. 2014;10(6):3320\u20133326. doi: 10.3892/mmr.2014.2633.", "ArticleIdList": ["10.3892/mmr.2014.2633", "25323558"]}, {"Citation": "Li F., Yang X., Yang Y., et al. Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine. 2013;20(6):549\u2013557. doi: 10.1016/j.phymed.2013.01.001.", "ArticleIdList": ["10.1016/j.phymed.2013.01.001", "23428402"]}, {"Citation": "Niu Y. B., Li Y. H., Kong X. H., et al. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. Osteoporosis International. 2012;23(11):2649\u20132660. doi: 10.1007/s00198-012-1932-y.", "ArticleIdList": ["10.1007/s00198-012-1932-y", "22535190"]}, {"Citation": "Zhang R., Hu S. J., Li C., Zhang F., Gan H. Q., Mei Q. B. Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats. Journal of Ethnopharmacology. 2012;139(1):12\u201318. doi: 10.1016/j.jep.2011.05.034.", "ArticleIdList": ["10.1016/j.jep.2011.05.034", "21669273"]}, {"Citation": "Shen Y., Li Y. Q., Li S. P., Ma L., Ding L. J., Ji H. Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins. Journal of Natural Medicines. 2010;64(3):336\u2013345. doi: 10.1007/s11418-010-0416-7.", "ArticleIdList": ["10.1007/s11418-010-0416-7", "20376572"]}, {"Citation": "Chawalitpong S., Sornkaew N., Suksamrarn A., Palaga T. Diarylheptanoid from Curcuma comosa Roxb. suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway. European Journal of Pharmacology. 2016;788:351\u2013359. doi: 10.1016/j.ejphar.2016.08.012.", "ArticleIdList": ["10.1016/j.ejphar.2016.08.012", "27523282"]}, {"Citation": "Peng X., He J., Zhao J., et al. Polygonatum sibiricum polysaccharide promotes osteoblastic differentiation through the ERK/GSK-3\u03b2/\u03b2-catenin signaling pathway in vitro. Rejuvenation Research. 2017 doi: 10.1089/rej.2017.1956.", "ArticleIdList": ["10.1089/rej.2017.1956", "28629266"]}, {"Citation": "Zhou W., Cheng X., Zhang Y. Effect of Liuwei Dihuang decoction, a traditional Chinese medicinal prescription, on the neuroendocrine immunomodulation network. Pharmacology & Therapeutics. 2016;162:170\u2013178. doi: 10.1016/j.pharmthera.2016.02.004.", "ArticleIdList": ["10.1016/j.pharmthera.2016.02.004", "26896567"]}, {"Citation": "Jian F., Yongxiang Z., Xiangbin R. Effect of Liuwei Dihuang decoction, a traditional Chinese medicinal tonic prescription, on the immune function of adjuvant arthritis rats. Pharmacology and Clinics of Chinese Materia Medica. 2001;1:3\u20135."}, {"Citation": "Jian F., Yongxiang Z., Xiangbin R. Effect of Liuwei Dihuang decoction on the cytokine expression in splenocytes in AA rats. China Journal of Chinese Materia Medica. 2001;2:56\u201359.", "ArticleIdList": ["12525111"]}, {"Citation": "Ge J. R., Xie L. H., Chen J., et al. Liuwei Dihuang pill (\u516d\u5473\u5730\u9ec4\u4e38) treats postmenopausal osteoporosis with Shen (kidney) yin deficiency via Janus kinase/signal transducer and activator of transcription signal pathway by up-regulating cardiotrophin-like cytokine factor 1 expression. Chinese Journal of Integrative Medicine. 2016 doi: 10.1007/s11655-016-2744-2.", "ArticleIdList": ["10.1007/s11655-016-2744-2", "28028720"]}, {"Citation": "Xia B., Xu B., Sun Y., et al. The effects of Liuwei Dihuang on canonical Wnt/\u03b2-catenin signaling pathway in osteoporosis. Journal of Ethnopharmacology. 2014;153(1):133\u2013141. doi: 10.1016/j.jep.2014.01.040.", "ArticleIdList": ["10.1016/j.jep.2014.01.040", "24530448"]}, {"Citation": "Liu M. J., Yan L. I., Pan J. H., et al. Effects of zuogui pill (\u5de6\u5f52\u4e38) on Wnt singal transduction in rats with glucocorticoid-induced osteoporosis. Journal of Traditional Chinese Medicine. 2011;31(2):98\u2013102. doi: 10.1016/S0254-6272(11)60020-4.", "ArticleIdList": ["10.1016/S0254-6272(11)60020-4", "21977807"]}, {"Citation": "Lai N., Zhang Z., Wang B., et al. Regulatory effect of traditional Chinese medicinal formula Zuo-Gui-Wan on the Th17/Treg paradigm in mice with bone loss induced by estrogen deficiency. Journal of Ethnopharmacology. 2015;166:228\u2013239. doi: 10.1016/j.jep.2015.03.011.", "ArticleIdList": ["10.1016/j.jep.2015.03.011", "25824592"]}]}], "History": [{"Year": "2017", "Month": "8", "Day": "24"}, {"Year": "2017", "Month": "11", "Day": "5"}, {"Year": "2017", "Month": "12", "Day": "6"}, {"Year": "2018", "Month": "4", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["29675436", "PMC5838472", "10.1155/2018/6345857"]}}]}